We are live on ! Find out more
LCTX icon

Lineage Cell Therapeutics

102 hedge funds and large institutions have $140M invested in Lineage Cell Therapeutics in 2017 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 42 increasing their positions, 19 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

121% more repeat investments, than reductions

Existing positions increased: 42 | Existing positions reduced: 19

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

0.87% less ownership

Funds ownership: 49.51%48.64% (-0.87%)

4% less call options, than puts

Call options by funds: $203K | Put options by funds: $212K

6% less funds holding

Funds holding: 109102 (-7)

7% less capital invested

Capital invested by funds: $151M → $140M (-$11.3M)

50% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 12

Holders
102
Holders Change
-7
Holders Change %
-6.42%
% of All Funds
2.54%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.05%
New
6
Increased
42
Reduced
19
Closed
12
Calls
$203K
Puts
$212K
Net Calls
-$9K
Net Calls Change
+$32K